This article is more than 5 years old. Information may no longer be current.

VIDEO: Ocular Therapeutix delivers update on Dextenza launch

ByScott Corning

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

NEW YORK — At the OSN New York 2019 meeting, Scott Corning, senior vice president of commercial, gives an update on the launch of Dextenza, the dexamethasone-eluting intracanalicular insert indicated for the management of inflammation and pain following ophthalmic surgery.